House Oversight Chair Carolyn Maloney dismissed pharmaceutical industry arguments that the drug price controls the Democrats are pursuing would limit efforts to develop new cures and therapeutics.Read More

House Oversight Chair Carolyn Maloney dismissed pharmaceutical industry arguments that the drug price controls the Democrats are pursuing would limit efforts to develop new cures and therapeutics.Read More